arrow
M

Majbritt Jeppesen

Aarhus University Hospital
H指数:8
被引数:290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis

在囊性纤维化患儿和成人中,引入elexacaftor/tezacaftor/ivacaftor前后,体重、线性生长和体成分的变化。

2025-09-240
PREAI
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort

Elexacaftor/Tezacaftor/Ivacaftor引入后严重肝毒性不常见:一项针对丹麦囊性纤维化队列的真实世界两年随访研究

2025-08-250
OAAI
Change in pulmonary pathogens three years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort

使用elexacaftor/tezacaftor/ivacaftor治疗三年后病原体在肺部的变化:一项在丹麦囊性纤维化队列中的观察性研究

2025-08-200
PREAI
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registries
2024-09-010
PRE
Serum C-peptide levels and breast cancer risk:: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
2006-05-0893
OAAI